drugset / Trial / NCT00161798
Dose-finding Study to Investigate the Safety and Immunogenicity of Two Vaccinations With FSME IMMUN NEW in Healthy Volunteers Aged 6 to 16 Years.
RandomizedParallel-groupDouble-blindPrevention
Summary
The purpose of this study is to investigate the safety and immunogenicity of three different concentrations of a TBE vaccine will be investigated in healthy children aged 6 to 16 years.
Timeline
- Start
- 2001-09
- Primary completion
- —
- Completion
- 2002-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | FSME IMMUN NEW | Vaccine | — | — |